Regulatory role of TIPE2 by inhibiting microglial pyroptosis and glycolysis in the treatment of sepsis‐associated encephalopathy
Regulatorische Rolle von TIPE2 durch Hemmung von Mikroglia-Pyroptose und Glykolyse in der Behandlung der sepsisassoziierten Enzephalopathie
Clinical and Translational Medicine · 2026-11 · 16 (11)
DOI: 10.1002/ctm2.70881 ↗Auf einen Blick
In Maus- und Zellmodellen der sepsisassoziierten Enzephalopathie war TIPE2 in Mikroglia vermindert. Ein TIPE2-Mangel verschlechterte kognitive Störungen und förderte Pyroptose und Glykolyse.
Fragestellung
Welche Rolle spielt TIPE2 bei der sepsisassoziierten Enzephalopathie und über welchen Mechanismus wirkt es in Mikroglia?
Methode
TIPE2-Expression per scRNA-seq und Immunfluoreszenz; SAE in CLP-Mäusen mit TIPE2-KO und WT. Zusätzlich primäre Mikroglia und BV2-Zellen mit LPS/Nigericin, Analysen u. a. per Western blot, GST-Pulldown und Co-IP.
Ergebnisse
scRNA-seq zeigte TIPE2 überwiegend in Mikroglia und bei SAE herunterreguliert. TIPE2-KO verschlechterte Kognition, förderte M1-Polarisation, Pyroptose, ROS und glykolytische Reprogrammierung; Rhosin kehrte dies um.
Schlussfolgerung der Autor:innen
TIPE2 schützt vor SAE, indem es direkt mit RhoA interagiert, dessen Aktivierung hemmt und dadurch NLRP3-vermittelte Mikroglia-Pyroptose und Glykolyse unterdrückt.
Kernaussagen
- TIPE2 war in Mikroglia predominant und bei SAE vermindert.
- TIPE2-Mangel verstärkte kognitive Störung, Pyroptose, ROS und Glykolyse.
- Rhosin hob die Folgen des TIPE2-Mangels teilweise auf.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 06.11.2026. Verfasst von Min Yuan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Pyroptosis, Microglia, Intracellular Signaling Peptides and Proteins, Sepsis-Associated Encephalopathy. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hubei Province.
Themen: Sepsis
Abstract (Originalsprache)
Background
Sepsis_associated encephalopathy (SAE) denotes acute cerebral dysfunction triggered by sepsis and is accompanied by high mortality. Our previous study showed that TIPE2 significantly ameliorated cognitive impairment in SAE mice by inhibiting neuroinflammation, but the specific mechanism was unknown.
Methods
TIPE2 expression and cell specificity were analysed by scRNA‑seq and immunofluorescence. To establish SAE, cecal ligation and puncture (CLP) was carried out in TIPE2 knockout (KO) and WT mice. Neuronal/synaptic damage was assessed by TUNEL and TEM; cognitive function by behavioural tests and EEG. Hippocampal scRNA‑seq compared WT and TIPE2 KO mice. In vitro, primary microglia and BV2 cells were stimulated with LPS/nigericin. Protein expression (Western blot/IF), RhoA activation (GST‑pulldown), glucose/lactate levels, ROS production, and TIPE2‑RhoA interaction (Co‑IP/confocal) were examined. Results scRNA‑seq confirmed that TIPE2 is predominantly expressed in microglia and downregulated in SAE; its deficiency promotes pro‑inflammatory microglia associated with pyroptosis and glycolysis. TIPE2 KO significantly aggravated cognitive impairment, promoted M1 polarisation, enhanced pyroptosis (GSDMD cleavage, caspase‑1 activation), and increased ROS production. Mechanistically, TIPE2 directly bound to RhoA and inhibited its activation, thereby suppressing NLRP3‑mediated pyroptosis and glycolysis in microglia. Treatment with the RhoA‑specific inhibitor Rhosin reversed TIPE2 deficiency‑induced microglial polarisation, pyroptosis, ROS production, and glycolytic reprogramming, and also ameliorated cognitive dysfunction in TIPE2 KO mice.
Conclusions
TIPE2 protects against SAE by directly interacting with RhoA, inhibiting its activation, and subsequently suppressing NLRP3‑mediated microglial pyroptosis and glycolysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
- Research Centre of Anesthesiology and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
- School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, China.
- Department of Immunology, School of Basic Medical Sciences, Wuhan University, Wuhan, Hubei, China.
- Department of Anesthesiology, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou, China.
ORCID-Profile: Huifan Liu, Guoqing Jing, Zhongyuan Xia, Xiaojing Wu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
Zitieren
APA
Yuan, M., Yang, Y., Liu, H., Kong, Q., Jing, G., Gong, H., Wang, Y., Zhang, Z., Liu, W., Song, X., Xia, Z., & Wu, X. (2026). Regulatory role of TIPE2 by inhibiting microglial pyroptosis and glycolysis in the treatment of sepsis‐associated encephalopathy. Clinical and Translational Medicine, 16(11). https://doi.org/10.1002/ctm2.70881
Vancouver
Yuan M, Yang Y, Liu H, Kong Q, Jing G, Gong H, et al. Regulatory role of TIPE2 by inhibiting microglial pyroptosis and glycolysis in the treatment of sepsis‐associated encephalopathy. Clinical and Translational Medicine. 2026;16(11). doi:10.1002/ctm2.70881
BibTeX
@article{Yuan2026,
author = {Yuan, Min and Yang, Yunzhao and Liu, Huifan and Kong, Qian and Jing, Guoqing and Gong, Hailong and Wang, Yuxuan and Zhang, Zhengyu and Liu, Wanhong and Song, Xuemin and Xia, Zhongyuan and Wu, Xiaojing},
title = {Regulatory role of TIPE2 by inhibiting microglial pyroptosis and glycolysis in the treatment of sepsis‐associated encephalopathy},
journal = {Clinical and Translational Medicine},
year = {2026},
volume = {16},
number = {11},
doi = {10.1002/ctm2.70881}
}
EUVIMED